Change Agents Corporation reported a net loss of $10.29 million for the nine months ended September 30, 2026, compared to a loss of $16.19 million in the prior year period. The company's balance sheet shows a significant reduction in total liabilities from $14.17 million at year-end 2025 to $6.62 million, primarily due to the settlement of liabilities related to discontinued operations.
Change Agents Corporation appointed Luisa Ingargiola, the company's current Chief Strategy Officer, as its principal executive officer effective November 4, 2026. She will serve in this role until a new Chief Executive Officer is appointed and will not receive additional compensation for the service. The company also issued a $250,000 promissory note to Harllon Holdings LLC and issued 150,000 shares to consultants for services rendered.
Change Agents Corporation held a special meeting where stockholders approved several proposals related to equity financing, including the potential issuance of shares under an Equity Purchase Agreement with Hudson Global Ventures, LLC. Stockholders also approved the issuance of shares upon the conversion of promissory notes held by Vanquish Funding Group and an amendment to increase authorized common stock from 100 million to 125 million shares. These approvals were primarily sought to comply with Nasdaq Listing Rule 5635(d) regarding the issuance of 20% or more of outstanding shares.
Change Agents Debt Financing Update with Dune Equity Holdings, LLC
Change Agents Corporation executed unsecured promissory notes totaling $250,000 with maturity dates of December 1, 2026. Additionally, the company entered into waivers with Dune Equity Holdings and FirstFire Global Opportunities Fund regarding prepayment provisions, issuing pre-funded warrants for 99,500 shares as consideration.
Change Agents Corporation appointed Eric Weisblum as an independent director to its board of directors, effective October 12, 2026. Mr. Weisblum, who is currently the CEO of Silo Pharma Inc, will serve on the Audit, Compensation, and Nominating and Corporate Governance Committees.
Meng Li has resigned from her roles as Interim CEO, COO, and Secretary of Change Agents Corporation, effective October 8, 2026. Her departure is intended to facilitate the company's preparation for a potential acquisition in the drone defense industry, and the Board has initiated a search for a replacement from the global defense and AI sectors.
Change Agents Debt Financing Update with certain accredited investors
Change Agents Corporation issued $336,000 in aggregate principal amount of original issue discount promissory notes for gross proceeds of $300,000. The notes mature on April 30, 2027, and the proceeds were used to repay existing indebtedness and for general corporate purposes. As an inducement, the company also issued pre-funded warrants to purchase 100,000 shares of common stock at a nominal exercise price.
Change Agents Debt Financing Update with certain accredited investors
Change Agents Corporation issued $280,000 in aggregate principal amount of original issue discount (OID) promissory notes maturing in April 2027. The notes carry a 7% annual interest rate and were issued for gross proceeds of $250,000, which will be used to repay existing debt and for working capital. As an inducement, the company also issued pre-funded warrants to purchase 100,000 shares of common stock.
Change Agents Debt Financing Update with Certain accredited investors
Change Agents Corporation issued $280,000 in original issue discount promissory notes to accredited investors for gross proceeds of $250,000. The notes mature on April 8, 2027, and carry a 7% annual interest rate, with proceeds used to repay existing debt and for general working capital. As an inducement, the company also issued pre-funded warrants to purchase 1,000,000 shares of common stock.